ReShape Lifesciences Inc. (NASDAQ:RSLS)’s traded shares stood at 0.65 million during the latest session, with the company’s beta value hitting 0.21. At the last check today, the stock’s price was $0.18, to imply an increase of 2.04% or $0.0 in intraday trading. The RSLS share’s 52-week high remains $4.10, putting it -2177.78% down since that peak but still an impressive 22.22% since price per share fell to its 52-week low of $0.14. The company has a valuation of $4.34M, with an average of 0.41 million shares in intraday trading volume over the past 10 days and average of 927.07K shares over the past 3 months.
ReShape Lifesciences Inc. (NASDAQ:RSLS) trade information
After registering a 2.04% upside in the latest session, ReShape Lifesciences Inc. (RSLS) has traded red over the past five days. The stock hit a weekly high of 0.1980, jumping 2.04% in its intraday price action. The 5-day price performance for the stock is 3.88%, and 7.19% over 30 days. With these gigs, the year-to-date price performance is -25.95%. Short interest in ReShape Lifesciences Inc. (NASDAQ:RSLS) saw shorts transact 0.43 million shares and set a 0.64 days time to cover.
ReShape Lifesciences Inc. (RSLS) estimates and forecasts
Revenue is forecast to grow 97.90% this quarter before jumping 89.70% for the next one. The rating firms project that company’s revenue will shrink -20.80% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is $2.21 million. Meanwhile, for the quarter ending Mar 2024, a total of 1 analyst(s) estimate revenue growth to $2.1 million.Earnings reports from the last fiscal year show that sales brought in $3.11 million and $2.29 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -28.90% before dropping -8.20% in the following quarter.
RSLS Dividends
ReShape Lifesciences Inc. has its next earnings report out between April 15 and April 19. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. ReShape Lifesciences Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
ReShape Lifesciences Inc. (NASDAQ:RSLS)’s Major holders
ReShape Lifesciences Inc. insiders hold 11.16% of total outstanding shares, with institutional holders owning 1.97% of the shares at 2.21% float percentage. In total, 1.97% institutions holds shares in the company, led by Two Sigma Securities, LLC. As of Dec 30, 2023, the company held over 75579.0 shares (or 0.58% of shares), all amounting to roughly $13868.0.
The next major institution holding the largest number of shares is Virtu Financial LLC with 73532.0 shares, or about 0.56% of shares outstanding. As of the market price on Dec 30, 2023, these shares were worth $13493.0.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the ReShape Lifesciences Inc. (RSLS) shares. Going by data provided on Dec 30, 2023, Vanguard Extended Market Index Fund holds roughly 49874.0 shares. This is just over 0.38% of the total shares, with a market valuation of $9151.0. Data from the same date shows that the other fund manager holds a little less at 17799.0, or 0.14% of the shares, all valued at about 3266.0.
